Skip to main content
OpenTrials

Clinical trial condition

Plasma Cell Myeloma

Explore clinical trials studying Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

79 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Plasma Cell Myeloma trial results

Completed

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

NCT03275285

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCSF MS Center Site Number : 8400002 San Francisco, California, United States
  • Spartanburg Medical Center Site Number : 8400003 Spartanburg, South Carolina, United States
  • Investigational Site Number : 0360005 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360006 Tweed Heads, New South Wales, Australia
View all 70 locations
View Trial Details
Completed

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

NCT04000282

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Site Number : 8400002 Duarte, California, United States
  • Dana Farber Cancer Institute Site Number : 8400003 Boston, Massachusetts, United States
  • Mayo Clinic of Rochester Site Number : 8400005 Rochester, Minnesota, United States
  • UNC Chapel Hill Site Number : 8400006 Chapel Hill, North Carolina, United States
View Trial Details

Related conditions